Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M5,760Revenue $M2,541Net Margin (%)0Z-Score0
Enterprise Value $M5,760EPS $1.6Operating Margin %0F-Score0
P/E(ttm))0Cash Flow Per Share $0Pre-tax Margin (%)0Higher ROA y-yN
Price/Book010-y EBITDA Growth Rate %0Quick Ratio0Cash flow > EarningsN
Price/Sales05-y EBITDA Growth Rate %0Current Ratio0Lower Leverage y-yN
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)0Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)0Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M0ROI % (ttm)0Gross Margin Increase y-yN

Gurus Latest Trades with WCRX

Number of guru portfolios checked: 56. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
WCRXMario Gabelli 2013-09-30 Sold Out $19.36 - $22.27
($21.08)
$ 22.939%Sold Out0
WCRXJoel Greenblatt 2013-09-30 Reduce-0.16%$19.36 - $22.27
($21.08)
$ 22.939%Reduce -16.2%1,026,192
WCRXMario Gabelli 2013-06-30 Buy $13.4 - $20.61
($16.94)
$ 22.9335%New holding, 16500 sh.16,500
WCRXJoel Greenblatt 2013-03-31 Buy 0.94%$12.04 - $14.59
($13.6)
$ 22.9369%New holding, 1366561 sh.1,366,561
WCRXJohn Keeley 2013-03-31 Sold Out -0.0031%$12.04 - $14.59
($13.6)
$ 22.9369%Sold Out0
WCRXVanguard Health Care Fund 2012-06-30 Sold Out -0.04%$15.29 - $21.93
($18.59)
$ 22.9323%Sold Out0
WCRXVanguard Health Care Fund 2012-03-31 Add0.02%$15.74 - $17.47
($15.62)
$ 22.9347%Add 129.2%532,200
WCRXJoel Greenblatt 2012-03-31 Sold Out -0.18%$15.74 - $17.47
($15.62)
$ 22.9347%Sold Out0
WCRXJoel Greenblatt 2011-12-31 Add0.13%$13.33 - $18.68
($16)
$ 22.9343%Add 256.19%96,812
WCRXJoel Greenblatt 2011-09-30 Reduce-0.1%$13.67 - $24.62
($18.62)
$ 22.9323%Reduce -53.17%27,180
WCRXJoel Greenblatt 2011-06-30 Buy 0.2%$22.19 - $25.73
($23.72)
$ 22.93-3%New holding, 58040 sh.58,040
WCRXMario Gabelli 2011-03-31 Sold Out $22 - $25.01
($23.5)
$ 22.93-2%Sold Out0
WCRXJohn Keeley 2011-03-31 Buy $22 - $25.01
($23.5)
$ 22.93-2%New holding, 9415 sh.9,415
WCRXGeorge Soros 2011-03-31 Sold Out $22 - $25.01
($23.5)
$ 22.93-2%Sold Out0
WCRXGeorge Soros 2010-12-31 Buy $19.02 - $25
($22.03)
$ 22.934%New holding, 8900 sh.8,900
WCRXMario Gabelli 2010-12-31 Buy $19.02 - $25
($22.03)
$ 22.934%New holding, 10000 sh.10,000
WCRXVanguard Health Care Fund 2009-12-31 Buy 0.04%$21.22 - $28.45
($24.51)
$ 22.93-6%New holding, 232200 sh.232,200
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

WCRX is held by these Gurus:

Premium Most recent portfolio changes are included for Premium Members only!


WCRX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
BAIN CAPITAL INVESTORS LLC10% Owner 2009-11-25Sell3,946,020$22.253.06 view
CONNAUGHTON JOHNDirector, 10% Owner 2009-11-25Sell3,946,020$22.253.06 view
Ellman HermanSenior V.P., Clinical Devel. 2009-01-12Sell1,018$1463.79 view
Howard Alvin DSr. V.P., Regulatory Affairs 2009-01-12Sell1,120$1463.79 view
Cross Leland HSenior V.P., Tech. Operations 2009-01-12Sell1,018$1463.79 view
Cross Leland HSenior V.P., Tech. Operations 2008-09-22Sell1,150$15.349.87 view
Howard Alvin DSr. V.P., Regulatory Affairs 2008-09-22Sell1,396$15.349.87 view
Ellman HermanSenior V.P., Clinical Devel. 2008-09-22Sell1,129$15.349.87 view
BLOEM JAMES HDirector 2008-03-13Buy2,500$16.439.82 view
Burgstahler David FDirector 2008-03-07Buy10,000$15.6546.52 view

Press Releases about WCRX :

    Quarterly/Annual Reports about WCRX:

      News about WCRX:

      Articles On GuruFocus.com
      My 5 Favorite High Beta Health Care Dividend Stocks Aug 02 2013 
      4 Top-Performing Healthcare Dividend Stocks with Single-Digit P/Es Jul 02 2013 
      'Magic Formula' Inventor Joel Greenblatt New Buys Rundown May 24 2013 
      My 4 Favorites From The 20 Cheapest Healthcare Dividend Stock List May 02 2013 
      comment on WCRX Apr 21 2013 
      Weekly Guru Bargains Highlights: WCRX, IOC, QCOR, PWE, PGH Dec 30 2012 
      Weekly Guru Bargains Highlights: BIG, RATE, WCRX, BPT, MCP Dec 24 2012 
      4 International Stocks at 52-Week Lows – December 2012 Edition Dec 14 2012 
      many gurus, turn aro Oct 15 2012 
      Weekly Guru Bargains Highlights: WCRX, NIHD, EBR, CAJ, CIG Oct 06 2012 

      More From Other Websites
      According to the Supreme Court, Corporations Have More Religious Freedom Than Taxpayers Jun 30 2014
      Regan: Taxes spur foreign corporate 'marriages' May 13 2014
      Merck, Apple, BMW, Google: Intellectual Property Dec 26 2013
      Merck Sues Actavis Unit Over Patent for Generic NuvaRing Dec 24 2013
      Dec 16, 2013 Zimmer Holdings Names Paul Bisaro to Board of Directors Dec 16 2013
      Zydus Pharmaceuticals (USA) Inc agreement with Warner Chilcott Company LLC Dec 13 2013
      FTC order settles charges that Warner Chilcott acquisition is anticompetitive Dec 11 2013
      WARNER CHILCOTT PLC Files SEC form 8-K, Entry into a Material Definitive Agreement, Termination of a... Oct 03 2013
      Actavis, Inc. -- Moody's Affirms Actavis' Ratings; Upgrades Warner Chilcott's Senior Notes to Baa3 Oct 01 2013
      Actavis completes acquisition of Warner Chilcott Oct 01 2013
      Actavis Completes Warner Chilcott Acquisition Oct 01 2013
      Actavis a Step Closer to WCRX Sep 30 2013
      Actavis and Warner Chilcott Receive Approval from Irish High Court For Pending Warner Chilcott... Sep 30 2013
      4 Healthcare Stock Stories for Weekend Investment Wellness Sep 27 2013
      Stocks Fall In Mixed Volume; MercadoLibre Breaks Out Sep 27 2013
      FTC signs off on Actavis-Warner Chilcott deal Sep 27 2013
      Stocks Back Off In Mixed Volume; Celgene Hits New High Sep 27 2013
      Actavis FTC Accord Clears Way for Warner Chilcott Deal Sep 27 2013
      U.S. removes roadblock to Actavis-Warner Chilcott deal Sep 27 2013

      Add Notes, Comments

      If you want to ask a question, or report a bug, please create a support ticket.

      User Comments

      No comment yet
      Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
      GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
      Free 7-day Trial
      FEEDBACK